Search Results - "Thomas, Shrina"
-
1
Reduced-Dose Venetoclax Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults
Published in Blood (23-11-2021)“…Venetoclax is a potent selective inhibitor of the anti-apoptotic protein B-Cell Lymphoma 2 (BCL2) on tumor cells restoring the process of apoptosis among…”
Get full text
Journal Article -
2
Reduced-Dose Ibrutinib Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults
Published in Blood (23-11-2021)“…Ibrutinib is an inhibitor of Bruton's tyrosine kinase (BTK) that is used for the treatment of multiple hematologic malignancies including chronic lymphocytic…”
Get full text
Journal Article -
3
Assessing the discordance rate of HER2 expression by immunohistochemistry between primary and secondary prostate cancer biopsies
Published in Journal of clinical oncology (01-06-2023)“…e17014 Background: Preliminary evidence suggests that human epidermal growth factor receptor 2 (HER2) expression may play a role in tumor cell proliferation in…”
Get full text
Journal Article